title: Methylenetetrahydrofolate reductase polymorphism associated with moderate hyperhomocysteinaemia in a patient with livedo vasculopathy: treatment with vitamin supplementation and low molecular weight heparin.
authors.forename: J
authors.initials: J
authors.lastname: Rampf
authors.forename: C
authors.initials: C
authors.lastname: Sunderkötter
authors.forename: G
authors.initials: G
authors.lastname: Hirschfeld
authors.forename: K
authors.initials: K
authors.lastname: Scharffetter-Kochanek
authors.forename: J M
authors.initials: JM
authors.lastname: Weiss
mesh_terms: D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D020138:Hyperhomocysteinemia / Q000235:genetics*; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D011110:Polymorphism, Genetic; D017445:Skin Diseases, Vascular / Q000235:genetics*; D014815:Vitamins / Q000627:therapeutic use
chemical_list: D006495:Heparin, Low-Molecular-Weight; D014815:Vitamins; D042965:Methylenetetrahydrofolate Reductase (NADPH2)